(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Taylor Wimpey: Berenberg reiterates buy with a target price of 210p.
Centamin: Berenberg reiterates buy with a target price of 133p.
Litigation Capital Management: Canaccord reiterates buy with a target price of 94p.
Helium One Global: Canaccord initiates at speculative buy with a target price of 20p.
Ultra Electronics: JP Morgan reiterates overweight with a target price of 2,500p.
Croda: JP Morgan reiterates underweight with a target price of 5,550p.
AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.
GSK: Deutsche Bank reiterates sell with a target price of 1,150p.
Reckitt Benckiser: Barclays reiterates overweight with a target price of 9,100p.
Cineworld: Peel Hunt downgrades to hold with a target price of 105p.
Knights: Liberum reiterates buy with a target price of 500p.
Ergomed: Numis downgrades to add with a target price of 1,330p.
Bunzl: RBC Capital Markets upgrades to sector perform with a target price of 2,270p.
30 Apr 2020 07:28
UPDATE 2-Reckitt Benckiser's sales surge on coronavirus disinfectant boom
* Q1 sales up a record 13.3%* Forecasts stronger than expected 2020 performance* Production in some categories ramped up 50%* Shares up 3.2% (Adds analyst quote, comparison with peers, shares)By Siddharth CavaleApril 30 (Reuters) - Reckitt Benckiser...
Read more